Labeling, Warnings, and Advertising Claims in Food
Event | 06.19.13, 12:00 AM UTC - 12:00 AM UTC
The Food and Drug Administration (FDA) and the Federal Trade Commission (FTC) provide guidance that instructs food companies with respect to being truthful and not-misleading, and detailed regulations are available as to computing the values in nutrition facts panels. Translating this information to simple consumer-friendly messages has led to complaints from regulators and consumers, as well as legal actions.
This webinar will focus on strategies for minimizing such complaints while still providing consumers with more information about the product.
Attendees will gain an understanding of the variations of how people process food label information, attitudes toward the information, and purchasing behavior that can be used to undermine the very premise upon which these types of class action lawsuits rest.
This webinar will examine the following:
- The correct interpretation of some words such as “safe” “natural,” “GMO free,” and “does not contain GMO” are at the center of many of the complaints.
- The scientific data available to help you to challenge assumptions of homogeneity among food item purchasers in their cognitive processing of food labeling.
- The scientific research on human attention, perception, comprehension, and decision making.
- Consumers’ likelihood of noticing, understanding, and valuing of information on a food labels.
- Heterogeneity in consumer attitude and behavior as it relates to the validity of the assumption that consumers purchasing certain products represent a uniform collective of individuals.
- A review of relevant statutes and litigation arising from food labeling issues and claims.
For more information, please visit these areas: Litigation and Trial, Product Risk Management
Insights
Event | 02.20.25
Has the Buss Stopped? Recoupment Today
Has the Buss Stopped? Recoupment Today: In 1997, the California Supreme Court decided Buss v. Superior Court. In Buss, the court concluded that a liability insurer that defended a mixed action could seek reimbursement from the insured for the defense costs associated with the claims that were not even potentially covered. Since then, numerous courts have held that insurers are entitled to recoup their defense costs associated with uncovered claims or causes of action. On the other hand, a significant number of courts have rejected insurers’ right to recoupment, at least in the absence of a policy provision granting the insurer that right. Some commentators have even suggested that the current judicial trend might be away from permitting insurers to recoup their defense costs. Is that correct? Has the Buss stopped? This panel of coverage experts will analyze insurers’ claimed right to recoupment today, and offer their perspectives on what the law on recoupment should perhaps be and might be in the future.
Event | 12.05.24
Event | 12.05.24
Event | 12.04.24
Inside the Arbitrators’ Chambers: Best Practices of Arbitrators